Nippon Shinyaku Co.,Ltd
$22.7K 18 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Carter Bloodcare
Carter Bloodcare reported $22,624.82 across General Payments, Research, and Ownership to 109 physicians and teaching hospitals across 109 transactions.
- $22.6K Below-median payer
- All-tracks total
- 109 Below-median volume
- Transactions
- 109 Below-median reach
- Recipients
- −$5.8K
- General Payments vs PY2023
Carter Bloodcare reported $22,624.82 across all CMS Open Payments tracks (General + Research + Ownership) to 109 physicians and teaching hospitals in Program Year 2024 - ranking #1518 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $22,624.82, averaging $207.57 per recipient.
Carter Bloodcare's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
27/100
Total payments
F
10/100
Transaction volume
F
11/100
Physician reach
F
11/100
Payment type diversity
C
77/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer carter-bloodcare Carter Bloodcare
$22.6K · #1518/1,925 · 0.0% industry · PY2024
- TOT $22.6K
- RANK #1518
- SHARE 0.0%
- TXN 109
- RCP 109
- CAT 6
- GEN $22.6K
- ΔGEN −$5.8K
- TOP1 49.1%
- PY 2024
Volume peers
Nearest volume peer: Nippon Shinyaku Co.,Ltd ($22.7K)
Carter Bloodcare sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Carter Bloodcare's CMS-reported General Payments decreased by $5.8K (−20.4%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: CARTER BLOODCAREPY2023: CARTER BLOODCAREPY2024: CARTER BLOODCARE. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $28,411.41
- PY2024
- $22,624.82
What the Data Shows for Carter Bloodcare
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Carter Bloodcare that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
Of the 6 general-payment categories charted below, "Travel and Lodging" is the largest at $9.6K across 38 transactions, 42.6% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Carter Bloodcare made 6 types of general payments. "Travel and Lodging" is the largest category at $9.6K, 42.6% of General Payments.
Carter Bloodcare reports 6 general-payment categories - the top three are Travel and Lodging (42.6%), Compensation for Services Other Than Consulting (31.0%), and Education (11.7%). The remaining 3 categories make up 14.7% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Carter Bloodcare divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Travel and Lodging | $9.6K | 38 | 42.6% |
| Compensation for Services Other Than Consulting | $7.0K | 25 | 31.0% |
| Education | $2.7K | 6 | 11.7% |
| Food and Beverage | $2.6K | 36 | 11.6% |
| Gift | $358.97 | 2 | 1.6% |
| Entertainment | $340.00 | 2 | 1.5% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $18,162.53 (80.3%) of $22,624.82 in this company's General Payments records across 19 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Carter Bloodcare
The five named recipients with the highest reported General Payments from this company
- 1
Laurie Sutor
$11,100.34 across 52 reported transactions
- 2
Hillcrest Baptist Medical Center
$2,550.00 across 5 reported transactions
- 3
Christus Mother Frances Hosp-Tyler
$1,720.00 across 6 reported transactions
- 4
Medical City Dallas
$1,400.00 across 5 reported transactions
- 5
Barbara Bryant
$1,392.19 across 8 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Carter Bloodcare ranks #1518 of 1,925 by total payments (bottom 21% by spend) but is notably more concentrated than that alone would suggest -- #612 of 1,838 by HHI (top 33% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- Blue Sky Bio, LLC : $314.2K total payments, HHI 2746
- BTG International, Inc. : $670.8K total payments, HHI 2745
- Carbofix Orthopedics Inc : $49.7K total payments, HHI 2743
- Hyperfine Operations, Inc. : $52.4K total payments, HHI 2743
- 3NT Medical : $11.0K total payments, HHI 2735
- Boehringer Ingelheim Pharma GmbH & Co.KG : $27.7K total payments, HHI 2733
- Carter Bloodcare (this company) : $22.6K total payments, HHI 2730
- Kyowa Kirin Services Ltd : $24.7K total payments, HHI 2718
- Dentsply Sirona Orthodontics Inc : $133.4K total payments, HHI 2714
- Vitrolife Inc. : $31.3K total payments, HHI 2698
- Bard Peripheral Vascular, Inc. : $4.6M total payments, HHI 2695
- Eisai Co., Ltd. : $54.3K total payments, HHI 2691
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Carter Bloodcare's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Carter Bloodcare.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Carter Bloodcare.
Showing 6 of 1,924 companies with CMS-reported payment data.
CDC Medical LLC
$22.6K 231 recipients
Compare payment profiles
Terumo Cardiovascular Systems Corporation
$22.7K 185 recipients
Compare payment profiles
Reel Surgical, Inc.
$22.5K 214 recipients
Compare payment profiles
Innovative Medical Products, Inc.
$22.8K 14 recipients
Compare payment profiles
NovoSource, LLC
$22.9K 6 recipients
Compare payment profiles
Put this to use
Carter Bloodcare ranks #1518 of 1,925 by all-tracks total payments, led by "Travel and Lodging".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Travel and Lodging" spend across every manufacturer, not just Carter Bloodcare. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.